YOLO AdvisorShares Pure Cannabis ETF
ETF on NYSE (US) · Actively managed · Listing
Changes appear once four weeks of holdings are on file.
Largest holding: ADVISORSHARES PURE US CANN, 1.70M shares ($6.19M).
| Current positions Top 10 | % of book |
|---|---|
| ADVISORSHARES PURE US CANN MSOS $6.19M | 22.4% |
| Trulieve Cannabis Corp. TRLV $4.59M | 16.6% |
| CURALEAF HOLDINGS INC CURA $3.97M | 14.4% |
| Village Farms International, Inc. VFF $2.88M | 10.4% |
| High Tide Inc. HITI $2.04M | 7.4% |
| Aurora Cannabis Inc. ACB $1.98M | 7.2% |
| Cronos Group Inc. CRON $1.41M | 5.1% |
| SNDL Inc. SNDL $1.05M | 3.8% |
| Organigram Global Inc. OGI $656K | 2.4% |
| CHARLOTTES WEB HOLDINGS INC CWEB $605K | 2.2% |
Slices are % of holdings value.
| Sectors | % of holdings value |
|---|---|
| Consumer Defensive | 43.2% |
| Consumer Cyclical | 8.7% |
| Basic Materials | 7.2% |
| Unclassified | 40.9% |
| Industries | % of holdings value |
|---|---|
| Packaged Foods | 26.7% |
| Farm Products | 15.5% |
| Specialty Retail | 7.4% |
| Specialty Chemicals | 7.2% |
| Furnishings, Fixtures & Appliances | 1.3% |
| Beverages - Brewers | 0.9% |
| Unclassified | 40.9% |
Source: the fund's own published holdings, the portfolio of Nov 17, 2026 (advisorshares.com). Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Oct 30, 2026.
The AdvisorShares Pure Cannabis ETF (the "Fund") seeks long-term capital appreciation.
Principal investment strategies
The Fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business and in derivatives or other instruments that have economic characteristics similar to such securities. The Fund primarily invests in (i) exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies and (ii) an affiliated ETF that invests in such securities in the U.S. market and in total return swaps intended to provide exposure to such securities. The Fund also may invest directly in total return swaps intended to provide exposure to such U.S. and foreign securities. The Advisor also may seek investment opportunities through initial public offerings ("IPOs") and by investing in micro-capitalization companies. In addition to its investment in securities of companies that derive a significant portion of their revenue from the marijuana and hemp business and in derivatives providing exposure to such securities, the Fund may invest in securities of companies that, in the opinion of the Advisor, may have current or future revenues from cannabis-related business or that are registered with the Drug Enforcement Agency ("DEA") specifically for the purpose of handling marijuana for lawful research and development of cannabis or cannabinoid-related products. Cannabis securities may be categorized among a wide variety of sectors and industries including agriculture, biotechnology, pharmaceuticals, real estate, retail, and finance. The types of companies that may engage in cannabis-related business include companies that conduct medical research, produce drug products, manufacture hemp products, or engage in agricultural activities, real estate activities, or financial services activities. The terms "marijuana" and "cannabis" are used interchangeably. Hemp refers to the industrial/commercial use of the cannabis stalk and seed for textiles, foods, papers, body care products, detergents, plastics and building materials. Cannabinoids are the chemical compounds secreted by cannabis plants. Cannabinoids can also be synthetically produced chemical compounds and used in lawful research and development of prescription drugs or other products 2 utilizing cannabinoids as an active ingredient. The Advisor believes that continued legislative changes and social acceptance of cannabis in its various formats could lead to significant growth in cannabis-related public corporations. Companies involved in cannabis-related business could also benefit from significant merger and acquisition activity as the cannabis market matures. The Fund will not invest directly in or hold ownership in any companies that engage in cannabis-related business unless permitted by national and local laws of the relevant jurisdiction, including U.S. federal and state laws. The Fund concentrates (i.e., invests more than 25% of its total assets) in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The Fund is non-diversified and may invest a greater percentage of its assets in a particular issuer than a diversified fund. On a day-to-day basis, the Fund may hold money market instruments, cash, other cash equivalents, and exchange traded products that invest in these and other highly liquid instruments to collateralize its derivative positions. The Advisor may use a variety of methods for security selection. As the Fund primarily focuses on certain industries, the Advisor intends to select companies with dominant positions in their respective markets, or those in unique positions for growth and expansion. The Advisor will utilize numerous outside analyst ratings and stock selection rating tools.
Management and Contact
- Adviser
- AdvisorShares Investments, LLC
- Phone
- 877.843.3831
- [email protected]
- Website
- advisorshares.com/etfs/yolo
Holdings as of Nov 17, 2026
The full portfolio the fund publishes every business day on its website (advisorshares.com). Every line is listed: holdings we could identify link to their page, the rest (cash, options, swaps, private shares, securities we do not carry) are shown as the fund prints them. Short positions are negative. Change is the share count against Nov 16, 2026.
19 lines, 14 linked, weights sum to 100.00% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| ADVISORSHARES PURE US CANN | MSOS 00768Y453 | Equity | 1,696,425 | 0 | 22.38% | $ 6.192M |
| TRULIEVE CANNABIS CORP | TRLV 89790E106 | Equity | 455,882 | 0 | 16.60% | $ 4.591M |
|
CURALEAF HOLDINGS INC
|
CURA 23126M300 | Equity | 499,412 | 0 | 14.35% | $ 3.97M |
| VILLAGE FARMS INTERNATIONAL | VFF 92707Y108 | Equity | 1,256,750 | 0 | 10.40% | $ 2.878M |
| HIGH TIDE INC | HITI 42981E401 | Equity | 865,361 | 0 | 7.38% | $ 2.042M |
| AURORA CANNABIS INC | ACB 05156X850 | Equity | 439,135 | 0 | 7.18% | $ 1.985M |
| CRONOS GROUP INC | CRON 22717L101 | Equity | 441,930 | 0 | 5.10% | $ 1.41M |
| SNDL INC | SNDL 83307B101 | Equity | 787,107 | 0 | 3.81% | $ 1.055M |
| ORGANIGRAM GLOBAL INC | OGI 68617J100 | Equity | 928,665 | 0 | 2.37% | $ 656.473K |
| CHARLOTTES WEB HOLDINGS INC | CWEB BGHY2B1 | Equity | 3,456,457 | 0 | 2.19% | $ 604.826K |
| TERRASCEND CORP | TSNDF 88105E108 | Equity | 1,371,344 | 0 | 1.91% | $ 527.83K |
|
RUBICON ORGANICS INC
|
ROMJF 78112W100 | Equity | 1,587,445 | 0 | 1.43% | $ 395.623K |
| CANNARA BIOTECH INC | LOVE BMZMHL4 | Equity | 262,809 | 0 | 1.33% | $ 367.899K |
| GLASS HOUSE BRANDS INC | GLAS 377130406 | Equity | 219,558 | 0 | 1.32% | $ 364.466K |
| TILRAY BRANDS INC | TLRY 88688T209 | Equity | 109,007 | 0 | 0.93% | $ 256.166K |
| CANOPY GROWTH CORP | CGC 138035704 | Equity | 381,715 | 0 | 0.73% | $ 202.843K |
|
BLACKROCK TREASURY TRUST INSTL 62
|
X9USDBLYT | Money market | 138,544.05 | +99,078.94 | 0.50% | $ 138.544K |
|
CASH
|
Cash | 15,615.89 | โ99,458.91 | 0.06% | $ 15.616K | |
|
PHARMACIELO LTD
|
PCLOF 71716K101 | Equity | 301,797 | 0 | 0.03% | $ 8,465.41 |
Trades Nov 16, 2026 to Nov 17, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up